Kythera Biopharmaceuticals (KYTH -2.2%) may be giving back a little today, but the stock is...
Kythera Biopharmaceuticals (KYTH -2.2%) may be giving back a little today, but the stock is still holding steady above yesterdays IPO debut. The company sold 4.4M shares - 10% more than expected - and the $70.4M deal priced at the top of its range. The stock opened for trading yesterday at $18.49, up 16% from it's $16 offer price, and has held steady throughout both yesterday and today's sessions.
From other sites
at Zacks.com (Mar 10, 2015)
at Nasdaq.com (Mar 6, 2015)
at Zacks.com (Mar 6, 2015)
at CNBC.com (Nov 14, 2013)
at CNBC.com (Oct 7, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs